Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial evaluating the usability of a subcutaneous auto-injector for CT-P47 in patients with active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis [Phase 2]
Amgen's Phase 2 study evaluating the safety and efficacy of VIB4920 in rheumatoid arthritis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Rheumatoid Arthritis Memory B Cells and Abatacept [Phase 4]
Phase 4 trial evaluating abatacept's impact on memory B cells in rheumatoid arthritis; results were posted on 2023-02-06.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study of LY3462817 in Participants With Rheumatoid Arthritis [Phase 2]
Phase 2 trial update for LY3462817 in rheumatoid arthritis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE) [Phase 3]
Phase 3 trial of NI-071 in rheumatoid arthritis completed; results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life
A national observational study assessing the real-world use of Inflectra (infliximab biosimilar) across multiple inflammatory diseases compl…
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update evaluating a COVID-19 vaccine booster in immunocompromised individuals with rheumatic diseases.
-
CLINICAL_TRIALS trial_result · 2022-12-27Clinical Trial Update: Effect Of Moringa Leaf Extract On Disease Activity In Rheumatoid Arthritis Patients [Phase 1, Phase 2]
A clinical trial exploring the effects of moringa leaf extract on disease activity in rheumatoid arthritis patients has completed phases 1 a…
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis. [Phase 3]
Phase 3 trial evaluating the impact of one or two weeks of methotrexate discontinuation on the efficacy of influenza vaccination in rheumato…
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial update for ISIS 104838, an inhibitor targeting TNF, in active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: The Clinical Efficacy of Immunomodulators in RA Patients [Phase 4]
Phase 4 trial update evaluating the clinical efficacy of immunomodulators in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks [Phase 4]
A Phase 4 clinical trial comparing low-dose glucocorticoids versus tofacitinib for 24 weeks in moderate to high disease activity rheumatoid …
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Treatments Against RA and Effect on FDG-PET/CT [Phase 4]
Phase 4 clinical trial update evaluating treatments for rheumatoid arthritis and their effect on FDG-PET/CT imaging.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA [Phase 4]
Phase 4 trial evaluating the effectiveness and safety of Yisaipu combined with Tripterygium wilfordii for active rheumatoid arthritis has be…
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial update for MSB11456 in moderately to severely active rheumatoid arthritis; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-21Clinical Trial Update: Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of ILV-094 in rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 1, Phase 2]
A clinical trial update reports safety and efficacy findings for FURESTEM-RA Inj. in patients with moderate to severe rheumatoid arthritis a…
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis [Phase 3]
A Phase 3 trial update assessing the efficacy and safety of abatacept in combination with a JAK inhibitor for refractory rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation [Phase 4]
A Phase 4 trial evaluating rheumatoid arthritis treatment after first anti-TNF failed or investigated, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing PF-06410293 with Humira in combination with methotrexate for active rheumatoid arthritis has completed with results …
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA) [Phase 4]
Phase 4 trial assessing abatacept’s ability to silence anti-citrullinated protein antibody-expressing B cells in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial evaluating Januse kinase inhibition with filgotinib to silence autoreactive B cells in rheumatoid arthritis is ongo…
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate [Phase 2]
Phase 2 trial evaluating GLPG3970 as an oral treatment for 6 weeks in adults with moderately to severely active rheumatoid arthritis who had…
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Randomized Controlled RSA Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty. [NA]
Completed randomized controlled trial comparing Taperloc Complete vs Taperloc Complete Microplasty in hip arthroplasty; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis [Phase 2]
Open-label extension study assessing safety and efficacy of upadacitinib (ABT-494) in adults with rheumatoid arthritis.